AI-Powered Neonatal Risk Assessment for Improved Perinatal Outcomes

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-1
SponsorFetalFirst Limited

About this trial

This study aims to develop advanced artificial intelligence (AI) models that predict neonatal risks and complications based on historical multimodal health data, including ultrasound and MRI scans. The objective is to empower clinicians and provide clear, compassionate support for families navigating complex prenatal diagnoses.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Historical, de-identified neonatal records including ultrasound images, MRI scans, and clinical documentation available for analysis.

Disqualifiers

Cases with incomplete or missing critical data elements required for AI model analysis.

Trial population

The population includes retrospective, anonymized neonatal records obtained from clinical datasets, focusing on neonates previously diagnosed or assessed for congenital anomalies and neonatal risks.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

50,000 Participants
are grouped into 1 trial group
Group A: Retrospective Neonatal Data Cohort

Trial outcomes

Primary outcomes

1

Accuracy of AI Model Predictions for Neonatal Risk

Evaluate the accuracy of DenseNet121-based AI models in predicting neonatal risks and congenital anomalies, measured by sensitivity, specificity, and overall prediction accuracy.

Time frame
12 Months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: